We can't find the internet
Attempting to reconnect
18391.1 PFLS-LS
3-Dimensional Microtissues for Highly Predictive Drug Evaluation
Résumé
3-Dimensional Microtissues for Highly Predictive Drug Evaluation
Textes supplémentaires
Abstract
Failure rates in drug development are unsustainably high and are most often attributed to poor performance of|a lead compound regarding safety and/or efficacy. Improving the predictive power of preclinical stage in vitro|tests for new drug safety and efficacy is key to reducing attrition. CellSpring¿s 3D Bloom microtissue platform|has shown promise for achieving these goals. This CTI project will enable the development and validation of|3D microtissue models for preclinical drug safety, preclinical efficacy testing for novel chemotherapeutics, and|automated handling for high throughput applications.
Participants
Chris Millan
Wirtschaftspartner
chris.millan@cellspring.co
CellSpring AG Chris Millan HPL D 16.1 / Otto-Stern-Weg 7 8093 Zürich ETH-Hönggerberg ZH CH
Marcy Zenobi-Wong
Kontaktperson
marcy.zenobi@hest.ethz.ch
ETH Zürich Marcy Zenobi-Wong Otto-Stern-weg 7 8093 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2015-12-31
- Date de fin
- 2017-12-31
- Coûts totaux approuvés
- CHF 344679.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T115 Medical technology 100.0%